Kyivstar Group Ltd. finalized its purchase of Tabletki.ua for $160 million on February 10 2026, adding a high‑margin digital health marketplace to its portfolio. The deal values Tabletki.ua at an 8.0× price‑to‑earnings multiple based on its $24 million LTM EBITDA, underscoring the platform’s profitability and growth potential.
Tabletki.ua serves more than 14,000 pharmacies and processed roughly 14 million online bookings in 2025, generating a gross merchandise value of UAH 57.3 billion (≈$1.19 billion). Compared with the previous year, GMV grew 7.5 %, EBITDA rose 12 %, and net profit increased 9 %, reflecting a strengthening mix of high‑margin prescription sales and efficient logistics.
The acquisition aligns with Kyivstar’s strategy to transform from a traditional telecom operator into a comprehensive digital ecosystem. By integrating Tabletki.ua with its existing Helsi telehealth platform, Kyivstar can offer end‑to‑end medical services—from prescription ordering to home delivery—while cross‑selling to its Uklon ride‑hailing and Kyivstar TV customers. Management expects the new platform to generate an additional $30 million in annual recurring revenue within 12 months.
Kyivstar secured all necessary regulatory approvals, including clearance from the Antimonopoly Committee of Ukraine, which was granted on February 8 2026 after a brief review period. The company also announced a $1 billion investment plan in Ukraine for 2023‑2027, of which the Tabletki.ua purchase represents a significant portion aimed at expanding digital health and other high‑margin services.
“Tabletki.ua already plays a vital role in everyday life for millions of Ukrainians,” said Oleksandr Komarov, President of Kyivstar. “Combining our experience in scaling digital platforms with Tabletki.ua’s strong market position will accelerate the delivery of convenient, high‑quality healthcare services across the country.” CEO Kaan Terzioglu added that the deal reinforces Kyivstar’s commitment to investing in Ukraine’s digital future.
Analysts view the acquisition as a strategic win that will deepen Kyivstar’s penetration in the growing digital health market, which is projected to grow at a 15 % CAGR over the next five years. The transaction also positions Kyivstar to capture synergies in data analytics, customer engagement, and supply‑chain optimization that could lift overall operating margins by 1–2 percentage points over the next two years.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.